Icade SA (FR:ICAD) has released an update.
Icade’s long-term credit rating has been downgraded by S&P Global from BBB+ to BBB due to challenges in its business operations and delays in selling its Healthcare unit. Despite this, Icade remains committed to its strategic financial policies and maintains a strong liquidity position of €2.4 billion. The company continues to focus on sustainable real estate development across France.
For further insights into FR:ICAD stock, check out TipRanks’ Stock Analysis page.